1.Date of the board of directors' resolution:2023/05/12
2.Shareholders meeting date:2023/06/27
3.Shareholders meeting location:Howard Plaza Hotel 3F Dragon Hall
(located at No.160, Sec. 3, Jen Ai Road, Taipei City, Taiwan)
4.Shareholders' meeting will be held by means of (physical shareholders'
 meeting/ hybrid shareholders' meeting /
virtual-only shareholders' meeting):physical shareholders meeting
5.Cause for convening the meeting (1)Reported matters:
(1)2022 business report.
(2)Audit Committee's review report on 2022 financial results.
(3)2022 employees' and directors' and supervisors' remuneration.
(4)2022 directors' remuneration payment report. (New)
6.Cause for convening the meeting (2)Acknowledged matters:
(1)2022 Business Report and Financial Statements.
(2)Distribution of 2022 Earnings.
7.Cause for convening the meeting (3)Matters for Discussion:
(I)To authorize the Board of Directors to handle matters related of the cash
capital increase of Formosa Pharmaceuticals Inc. within the next year.
8.Cause for convening the meeting (4)Election matters:
To elect Independent Directors.
9.Cause for convening the meeting (5)Other Proposals:
Proposed release the Directors and their representatives from
non-competition restrictions.
10.Cause for convening the meeting (6)Extemporary Motions:None
11.Book closure starting date:2023/04/29
12.Book closure ending date:2023/06/27
13.Any other matters that need to be specified:None